ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,484Medicare Part D Prescriptions Filled, Including Refills

Rank: 223 out of 1000

$536K Total Retail Price of All Prescriptions

Rank: 231 out of 1000

240 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 240 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

49% of this provider’s 240 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 7,740 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,040 584 S3 1 1
LISINOPRIL 382 258 2 5
OMEPRAZOLE 316 236 3 2
METOPROLOL SUCCINATE 305 243 4 21
PRAVASTATIN SODIUM 297 210 5 12
LEVOTHYROXINE SODIUM 279 255 6 4
GLIMEPIRIDE 275 189 7 34
AMLODIPINE BESYLATE 255 203 8 6
METFORMIN HCL 238 168 9 8
GABAPENTIN 208 148 10 11
RANITIDINE HCL 202 93 11 37
OXYCODONE HCL-ACETAMINOPHEN 177 99 S2 12 138
POTASSIUM CHLORIDE 174 110 13 10
HYDROCHLOROTHIAZIDE 162 112 14 9
PREDNISONE 160 110 15 42
PANTOPRAZOLE SODIUM 160 114 15 28
SERTRALINE HCL 156 99 17 26
BUMETANIDE 151 120 18 112
FLUTICASONE PROPIONATE 146 92 19 40
CITALOPRAM HBR 133 100 20 17
ATORVASTATIN CALCIUM 130 92 21 18
FUROSEMIDE 128 95 22 7
ZOLPIDEM TARTRATE 127 74 23 16
MELOXICAM 113 85 24 14
COLESTIPOL HCL 102 66 25 327
TRAMADOL HCL 100 90 26 13
PROAIR HFA 99 57 27 50
KLOR-CON 10 97 80 28 104
CARVEDILOL 91 71 29 15
JANUVIA 89 55 30 85
LOSARTAN POTASSIUM 85 64 31 25
NEXIUM 84 60 32 23
ADVAIR DISKUS 83 54 33 65
TRIAMTERENE-HCTZ 80 57 34 48
METOPROLOL TARTRATE 76 66 35 19
ALLOPURINOL 76 53 35 31
NIASPAN 74 49 37 172
BYSTOLIC 72 48 38 126
LOVAZA 68 52 39 148
IMIPRAMINE HCL 65 46 R 40 361
METHOCARBAMOL 64 29 R 41 79
SPIRIVA 62 42 42 64
CIPROFLOXACIN HCL 62 50 42 46
DONEPEZIL HCL 61 61 44 32
METFORMIN HCL ER 58 44 45 44
CLOPIDOGREL 57 25 46 35
TRAZODONE HCL 57 24 46 29
ESCITALOPRAM OXALATE 57 48 46 60
GEMFIBROZIL 56 30 49 105
CEFUROXIME 55 39 50 133
SINGULAIR 54 30 51 84
MIRTAZAPINE 54 39 51 56
FLUOXETINE HCL 54 16 51 51
LANSOPRAZOLE 53 32 54 190
ENDOCET 52 40 S2 55 107
NAMENDA 50 50 56 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.